599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)

Autor: Carrasco, J., Beniuga, G., Jouret-Mourin, A., Baldin, P., Sinapi, I., Schroeder, D., De Cuyper, A., Sclafani, F., Hendlisz, A., van Laethem, J-L., Boulanger, A-S., Van Ooteghem, G., Dermine, A., Delmarcelle, S., Huyghe, N., Bar, I., van den Eynde, M.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S432-S432
Databáze: ScienceDirect